Gilead Sciences, Inc.
GILD
$134.43
-$1.79-1.31%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -12.17% | 2.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.18% | 2.01% | |||
| Cost of Revenue | -10.80% | 3.25% | |||
| Gross Profit | -12.53% | 1.69% | |||
| SG&A Expenses | -19.75% | 31.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.85% | 16.64% | |||
| Operating Income | -7.70% | -15.71% | |||
| Income Before Tax | 24.16% | -42.93% | |||
| Income Tax Expenses | 632.38% | -117.83% | |||
| Earnings from Continuing Operations | -7.42% | -28.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.42% | -28.47% | |||
| EBIT | -7.70% | -15.71% | |||
| EBITDA | -6.19% | -13.12% | |||
| EPS Basic | -7.42% | -28.42% | |||
| Normalized Basic EPS | -7.71% | -16.14% | |||
| EPS Diluted | -7.41% | -28.44% | |||
| Normalized Diluted EPS | -7.77% | -16.14% | |||
| Average Basic Shares Outstanding | 0.00% | -0.08% | |||
| Average Diluted Shares Outstanding | 0.08% | -0.08% | |||
| Dividend Per Share | 3.80% | 0.00% | |||
| Payout Ratio | 0.13% | 0.38% | |||